Agilon Health Q2 EPS $(0.25) Misses $(0.12) Estimate, Sales $1.395B Miss $1.472B Estimate
Author: Benzinga Newsdesk | August 04, 2025 05:28pm
Agilon Health (NYSE:
AGL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 113.68 percent. This is a 257.14 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $1.395 billion which missed the analyst consensus estimate of $1.472 billion by 5.24 percent. This is a 5.93 percent decrease over sales of $1.483 billion the same period last year.
Posted In: AGL